DESENEX Side Effects

6432293-3 | Arrhythmia, Electrocardiogram Qt Prolonged
on Oct 28, 2009 Female patient from SOUTH AFRICA , child 2 years of age, was treated with Desenex (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), electrocardiogram qt prolonged. Desenex dosage: .

6259370-4 | Hypercholesterolaemia, Hypertension, Off Label Use
Patient was taking Desenex (View Usage). Patient had the following side effects: hypercholesterolaemia, hypertension, off label use on Jun 26, 2009 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with hyperhidrosis and. Desenex dosage: Qd, Topical.

6221851-7 | Hypertension
Adverse event was reported on May 31, 2009 by a Male patient taking Desenex (View Usage) (Dosage: Qd, Topical) was diagnosed with fungal infection (What is fungal infection?) and. Location: UNITED STATES , 58 years of age, After Desenex was administered, patient had the following side effects: hypertension. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6130748-2 | Diabetes Mellitus, Off Label Use
on Mar 09, 2009 Female patient from UNITED STATES , 70 years of age, was diagnosed with hyperhidrosis and was treated with Desenex (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, off label use. Desenex dosage: Topical.


6105417-5 | Diabetes Mellitus, Hypercholesterolaemia
on Feb 26, 2009 Male patient from CANADA , 62 years of age, weighting 209.9 lb, was diagnosed with antifungal treatment and was treated with Desenex (View Usage). Patient had the following side effects: diabetes mellitus, hypercholesterolaemia. Desenex dosage: Unk, Qd, Topical. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6055190-4 | Cardiac Pacemaker Insertion, Hypertension, Osteoporosis
Patient was taking Desenex (View Usage). After Desenex was administered, patient had the following side effects: cardiac pacemaker insertion, hypertension, osteoporosis (What is osteoporosis?) on Jan 14, 2009 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with tinea pedis and. Desenex dosage: Qd Qw4, Topical. During the same period patient was treated with INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

5909126-4 | Activities Of Daily Living Impaired, Application Site Burn, Application Site Scab, Application Site Vesicles, Burns Second Degree, Injury, Pain, Pain In Extremity
Adverse event was reported on Sep 22, 2008 by a Male patient taking Desenex (View Usage) (Dosage: Qd, Topical) was diagnosed with tinea pedis and. Location: UNITED STATES , 42 years of age, weighting 274.9 lb, Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, application site burn, application site scab, application site vesicles, burns second degree, injury, pain (What is pain?), pain in extremity. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5869342-7 | Activities Of Daily Living Impaired, Application Site Burn, Application Site Scab, Application Site Vesicles, Burns Second Degree, Pain In Extremity, Scar
on Aug 09, 2008 Male patient from UNITED STATES , 42 years of age, weighting 274.9 lb, was diagnosed with tinea pedis and was treated with Desenex (View Usage). Patient had the following side effects: activities of daily living impaired, application site burn, application site scab, application site vesicles, burns second degree, pain in extremity, scar (What is scar?). Desenex dosage: Qd, Topical. During the same period patient was treated with LISINORPIL (LISINOPRIL) (View Lisinorpil (lisinopril) Review and Lisinorpil (lisinopril) Label ).

5818568-7 | Activities Of Daily Living Impaired, Application Site Burn, Application Site Vesicles, Burns Second Degree, Device Misuse, Scar
on Jul 14, 2008 Male patient from UNITED STATES , 42 years of age, was diagnosed with tinea pedis and was treated with Desenex (View Usage). After Desenex was administered, patient had the following side effects: activities of daily living impaired, application site burn, application site vesicles, burns second degree, device misuse, scar (What is scar?). Desenex dosage: Qd, Topical.

5805418-8 | Activities Of Daily Living Impaired, Application Site Burn, Application Site Vesicles, Burns Second Degree
Patient was taking Desenex (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, application site burn, application site vesicles, burns second degree on Jun 27, 2008 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with tinea pedis and. Desenex dosage: Qd, Topical.

5616271-X | Application Site Discolouration, Application Site Erythema, Application Site Vesicles, Hyperhidrosis, Hypersensitivity, Oedema Peripheral
Adverse event was reported on Jan 29, 2008 by a Male patient taking Desenex (View Usage) (Dosage: Once, Single, Topical) was diagnosed with tinea pedis and. Location: UNITED STATES , 54 years of age, weighting 175.0 lb, Patient had the following side effects: application site discolouration, application site erythema, application site vesicles, hyperhidrosis, hypersensitivity, oedema peripheral. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ).